Mark Fladrich
Member of the Corporate Executive Board, Chief Com
pharmaceutical sector
Grünenthal Group
Italy
Biography
He started a career in the pharmaceutical industry in 1988 and has been working on the commercial side of the business with AstraZeneca for 20 years.Since 2011 Mark Fladrich has worked in major commercial Profit & Loss roles, including the position of Country President for Australia and New Zealand and the position of Area Vice President Southern and Western Europe.In 2010, he was appointed Vice President Global Commercial Excellence with responsibility for pricing, market access, business insight, medical affairs, communications, sales, marketing, new channels capability development, portfolio management and forecasting.
Research Interest
Marketed products across all therapeutic areas (oncology, diabetes, respiratory, CNS).
